HeberFERON distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG.
J. Miranda, D. Vazquez-Blomquist, R. Bringas, J. Fernandez-de-Cossio, D. Palenzuela, L. I. Novoa, B.-R. J. Iraldo
This paper identifies molecular mechanisms of HeberFERON's distinct effect on the glioblastoma cell line U-87MG, showing its unique impact on the cell cycle.
bioRxiv · Sep 22, 2022 · PreprintCancer Biology